EUCTR2011-004815-22-DK进行中（未招募）不适用
Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1) - INDICES/WP2
Research Institute of Biological Psychiatry Sct. Hans0 个研究点开始时间: 2011年10月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy volunteers of both sexes
- •Age > 18 y
- •Caucasian race
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 45
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any chronic disease
- •Infection within the last 14 days
- •Regular use of medication
- •Alcohol intake
- •Known allergy to methylphenidate or trandolpril
研究者
相似试验
已完成
不适用
Study for personalized medicine based on pharmacokinetics and pharmacodynamics concerned with therapeutic drug of nontuberculous mycobacterium.JPRN-UMIN000020406Center for Infectious Disease and Infection Control10
招募中
不适用
pharmacoGenomic gUIDEd persONalized MEDicine: clinical settingNL-OMON56044Maasstadziekenhuis100
已完成
不适用
An integrative pharmacogenetic-pharmacometabolomic study to predict individualized pharmacokinetics of metoprolol in healthy male subjectsKCT0000449Kyungpook National University Hospital16
进行中（未招募）
不适用
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
招募中
Unknown
A study of polymorphism on cognitive decline in elderly breast cancer patients.Breast CancerJPRN-UMIN000050415Aichi Cancer Center Hospital100